Abstract
Background and purpose A proper stratification of intracranial aneurysms (IA) is critical in identifying rupture-destined aneurysms (RDA) and unruptured intracranial aneurysms (UIA). We aimed to determine the utility of geometric and hemodynamic indexes in differentiating RDA and UIA, and to examine the characteristics of natural evolutionary changes of UIA.
Methods RDA was defined as having subsequent subarachnoid hemorrhage (SAH), and UIA was examined using follow-up time-of-flight magnetic resonance angiography (TOF-MRA). In addition to geometric indexes such as aspect or size ratio, aneurysmal signal intensity gradient (SIG), an in-vivo approximated wall shear stress (WSS) from TOF-MRA, was measured. The difference (delta) between the maximum and minimum values of SIG in an aneurysm compared to parent arterial values was designated as the delta-SIG ratio.
Results This study analyzed 20 RDA in 20 patients and 45 UIA in 41 patients with follow-up TOF-MRA. While geometric indexes did not show significant differences between the RDA and UIA, the delta-SIG ratio was significantly higher in the RDA than in the UIA (1.5±0.6 vs. 1.1±0.3, P=0.032). The delta-SIG ratio showed a significantly higher area under the receiver operating characteristics curve for SAH than the size ratio (0.72 [95% confidence interval (CI), 0.58–0.87] vs. 0.56 [95% CI, 0.41–0.72], P=0.033). The longitudinal re-examination of TOF-MRA in the UIA group showed evidence of aneurysmal growth with hemodynamic stability.
Conclusions The delta-SIG ratio showed significantly higher discriminatory results between RDA and UIA compared to geometric indexes. Aneurysmal rupture risk should be assessed by considering both geometric and hemodynamic information.
This study was registered on ClinicalTrials.gov (NCT05450939).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study was registered on ClinicalTrials.gov (NCT05450939).
Funding Statement
This work was partly supported by the Technology Development Program of MSS, Korea (SKJ) and the Fund of the Korean Society of Neurosonology (CHL).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the institutional review board of Jeonbuk National University Hospital (CUH 2021-11-045-001).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
Our research data can be provided upon reasonable request.
